Video

The Emerging Role of Immunotherapy in Breast Cancer

"I think immunotherapy has certainly arrived for breast cancer," said Rita Nanda, MD.

Rita Nanda, MD: So the role of immunotherapy has really evolved this year, for both advanced-stage disease and hopefully for early-stage disease in the not-too-distant future. I think immunotherapy has certainly arrived for breast cancer. We saw our first approval advanced PDL-1+, triple-negative breast cancer earlier this year with the approval of atezolizumab and Nab-paclitaxel, based on the IMpassion130 trial. So there are a number of other trials going on that are helping us understand how better to sequence immunotherapy with chemotherapy; are there different chemotherapy backbones that might be as effective or more effective than nab-paclitaxel in any particular situation; as well as combination trials that are ongoing that hopefully will enhance and boost the number of patients who can benefit from immunotherapy in patients with advanced-stage disease.

Related Videos
Hands holding a crochet heart | Image Credit: © StockerThings - stock.adobe.com
Wooden blocks spelling HDL, LDL | Image Credit: © surasak - stock.adobe.com
Anticoagulant attacking blood clot | Image Credit: © BURIN93 - stock.adobe.com
Depiction of man aging | Image Credit: © Top AI images - stock.adobe.com
Map with pins | Image Credit: © Tryfonov - stock.adobe.com
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Image Credit: © abricotine - stock.adobe.com
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.